Key statistics
On Friday, Organon & Co (7XP:BER) closed at 17.70, -15.27% below its 52-week high of 20.89, set on Jul 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 18.06 |
---|---|
High | 18.14 |
Low | 17.58 |
Bid | 17.33 |
Offer | 17.60 |
Previous close | 17.93 |
Average volume | 408.10 |
---|---|
Shares outstanding | 257.47m |
Free float | 257.03m |
P/E (TTM) | 5.19 |
Market cap | 5.20bn USD |
EPS (TTM) | 3.89 USD |
Annual div (ADY) | 1.02 EUR |
---|---|
Annual div yield (ADY) | 5.67% |
Div ex-date | Aug 16 2024 |
Div pay-date | Sep 12 2024 |
Data delayed at least 15 minutes, as of Sep 20 2024 19:21 BST.
More ▼
Press releases
- Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
- Organon & Lilly Expand Migraine Commercialization Agreement to 11 Additional Markets
- Organon Reports Results for the Second Quarter Ended June 30, 2024
- Organon To Report Second Quarter 2024 Results and Host Conference Call on August 6, 2024